Whilst it's a good thing to follow Sprott, I wouldn't put too much credence on this change. Sprott has had a huge win with EMR and still receiving huge profits that are now locked in.
So it would be my guess that any downgrading of EMR would only be a reflection of them concentrating their efforts on other targets offering bigger returns going forward.
EMR Price at posting:
$2.83 Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)